HER2 Support Group Forums - New data demonstrating the strength of Novartis' hematology portfolio to be presented

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - New data demonstrating the strength of Novartis' hematology portfolio to be presented (https://her2support.org/vbulletin/showthread.php?t=42189)

News	12-02-2009 05:14 AM

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients.

More...

All times are GMT -7. The time now is 06:23 AM.